id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0033-0098,FDA,FDA-2002-N-0033,Supplement from Stake Holders Conference Calls,Other,SUP-Supplement,2004-07-30T04:00:00Z,2004,7,,,2015-04-08T17:25:49Z,,0,0,090000648048adbc
FDA-2002-N-0033-0095,FDA,FDA-2002-N-0033,Notice of Final Rule from FDA/CFSAN re pages 101 thru 200,Notice,Notice of Final Rule,2004-06-10T04:00:00Z,2004,6,2004-05-27T04:00:00Z,,2015-04-08T17:16:15Z,,0,0,090000648048adb3
FDA-2002-N-0033-0097,FDA,FDA-2002-N-0033,Notice of Final Rule from FDA/CFSAN re pages 201 thru 250,Notice,Notice of Final Rule,2004-06-10T04:00:00Z,2004,6,2004-05-27T04:00:00Z,,2015-04-08T17:17:44Z,,0,0,090000648048adba
FDA-2002-N-0033-0096,FDA,FDA-2002-N-0033,Notice of Final Rule from FDA/CFSAN re pages 1 thru 100,Notice,Notice of Final Rule,2004-06-10T04:00:00Z,2004,6,2004-05-27T04:00:00Z,,2015-04-08T17:15:52Z,,0,0,090000648048adb7